Evaluation of the judicialization of medicines in the public health sector in Rio Grande do Sul State, Brazil, from 2010 to 2019
Objective: identify the ten most legally demanded medicines in the State of Rio Grande do Sul, Brazil, and study the evolution of expenditures related to the judicialization of medicines from 2010 to 2019, comparing the data with the implementation of public policies on medicines in Brazil during th...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | Brasil |
| Institución: | Fundação Oswaldo Cruz (FIOCRUZ) |
| Repositorio: | Cadernos Ibero-Americanos de Direito Sanitário (Online) |
| Idioma: | portugués |
| OAI Identifier: | oai:ojs.cadernos.prodisa.fiocruz.br:article/839 |
| Acceso en línea: | https://www.cadernos.prodisa.fiocruz.br/index.php/cadernos/article/view/839 |
| Access Level: | acceso abierto |
| Palabra clave: | Health Judicialization Access to Medicines Public Health Policies Pharmaceutical Care Judicialización en Salud Acceso a Medicamentos Políticas de Salud Pública Asistencia Farmacéutica Judicialização da Saúde Acesso a Medicamentos Políticas Públicas de Saúde Assistência Farmacêutica |
| Sumario: | Objective: identify the ten most legally demanded medicines in the State of Rio Grande do Sul, Brazil, and study the evolution of expenditures related to the judicialization of medicines from 2010 to 2019, comparing the data with the implementation of public policies on medicines in Brazil during this period. Methods: this is a descriptive, retrospective, cross-sectional study using data from reports of the Medicines Management System of the Health Office and public data from the Transparency Portal, both from the State of Rio Grande do Sul. Results: tiotropium bromide 2.5 mcg topped the list of most frequently court-ordered medications and has topped this list every year since 2011. Citalopram 20 mg, venlafaxine 75 mg, and duloxetine 60 mg were the most frequently requested antidepressants, as were glucosamine sulfate 500 mg in association with chondroitin 400 mg, and rivaroxaban 20 mg. Antineoplastics were responsible for the largest state budget impact. Between 2010 and 2019, the State of Rio Grande do Sul’s expenditures increased by 773.1% due to the judicialization of pharmaceuticals. Conclusion: the phenomenon of judicialization of medicines in the State of Rio Grande do Sul has experienced significant growth during the period studied, and the adoption of public policies of pharmaceutical support does not seem to have affected access to medicines through judicialization. Received: 06/03/20 | Accepted: 09/30/22 |
|---|